PACE trial and other clinical data sharing: patient privacy concerns and parasite paranoia
Data sharing is all over academic news now. We had Research Parasites, a noxious species of scientists who want toContinue Reading
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Data sharing is all over academic news now. We had Research Parasites, a noxious species of scientists who want toContinue Reading
“I don’t ask TGA staff to risk their lives at work, only that they don’t risk mine and others’ lives by withholding public health information.” – Robert Cockburn
The court trial against me by German trachea transplanters Heike and Thorsten Walles ended with the settlement in the appeal courtContinue Reading
Researchers have removed the previously openly available anonymised patient data of the clinical trial FINE from their publication in PLOSContinue Reading
Schneider Shorts 10.09.2021: featuring Progressive Eugenics, lactoferrin back as COVID-19 miracle cure, proxalutamide banned, with a secret game-changer from Texas and a not-so-secret-anymore drug from France, does one really need ethics approvals to torture small animals, and why stealthily taking industry bribes is not research misconduct.
On March 22nd, Tom Reller, Head of Global Corporate Relations for the publishing giant Elsevier, declared the often criticised andContinue Reading
Schneider Shorts 27.01.2023 – Michigan professor out after fraud findings, Elsevier’s recruits Vietnam’s most-cited scholar as EiC, much-retracted gynecologist from Egypt loses PhD in Netherlands, anti-aging goes to the dogs, how to get fit, and finally, how an intrepid journal hunts the biggest research fraudster in science’s history.
Schneider Shorts 20.012023 – an Imperial retraction, investigators appointed in Stanford, a sexual harasser arrives in Harvard, greedy crook reverses aging, with another Cassava paper whitewashed, the secret of high impact factors, why some Italian fraudster’s papers are safe.
Schneider Shorts 13.01.2023 – confidential whitewashing in Australia, hallmarks of fraud in Cell, Nature journals welcome Count Facula and a Greek cheater, with FDA’s new Alzheimer’s drug, a German editor who can’t stop papermilling, an Italian art lover in Ohio, and why Smut Clyde will never get full credit.